Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,876 | -55,350 | -65,336 | -65,321 | -36,210 |
| Depreciation Amortization | 734 | 572 | 874 | 983 | 995 |
| Accounts receivable | -2,224 | -5,000 | N/A | 152 | 610 |
| Accounts payable and accrued liabilities | -57 | -600 | -516 | -2,327 | 2,686 |
| Other Working Capital | 85,002 | -4,481 | -781 | 7,132 | 13,129 |
| Other Operating Activity | 20,302 | 13,424 | 6,598 | 7,355 | -967 |
| Operating Cash Flow | $34,881 | $-51,435 | $-59,161 | $-52,026 | $-19,757 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 154 | 26,057 | -1,369 | -21,516 |
| PPE Investments | -741 | 75 | -785 | -729 | -584 |
| Investing Cash Flow | $-741 | $229 | $25,272 | $-2,098 | $-22,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,736 | N/A | N/A | 20,957 | N/A |
| Debt Repayment | -19,313 | -2,800 | N/A | -12,934 | N/A |
| Common Stock Issued | 3,464 | 32,126 | 697 | 10,886 | 71,762 |
| Other Financing Activity | 5,544 | 75,715 | 0 | 47,114 | -4,103 |
| Financing Cash Flow | $14,431 | $105,041 | $697 | $66,023 | $67,659 |
| Exchange Rate Effect | -58 | 34 | -153 | 78 | 463 |
| Beginning Cash Position | 91,551 | 37,682 | 71,027 | 59,050 | 32,785 |
| End Cash Position | 140,064 | 91,551 | 37,682 | 71,027 | 59,050 |
| Net Cash Flow | $48,513 | $53,869 | $-33,345 | $11,977 | $26,265 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,881 | -51,435 | -59,161 | -52,026 | -19,757 |
| Capital Expenditure | -815 | -47 | -884 | -733 | -586 |
| Free Cash Flow | 34,066 | -51,482 | -60,045 | -52,759 | -20,343 |